Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Clinical trial NCT06924606 · RECRUITING
Trial details
- NCT number
- NCT06924606
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2026-06-26
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.